Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study

Tatjana Rundek, Sabita Roy, Mady Hornig, Ying Kuen Cheung, Hannah Gardener, Janet DeRosa, Bonnie Levin, Clinton B. Wright, Victor A. Del Brutto, Mitchell SV Elkind, Ralph L. Sacco
doi: https://doi.org/10.1101/2020.09.15.20195362
Tatjana Rundek
aDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabita Roy
bSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mady Hornig
cDepartment of Epidemiology, Columbia University Medical Center, New York, NY
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ying Kuen Cheung
dDepartment of Biostatistics, Mailman Public School of Health, Columbia University, New York, NY
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah Gardener
aDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL
ScD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hgardener@med.miami.edu
Janet DeRosa
eDepartment of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bonnie Levin
aDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clinton B. Wright
fNational Institute of Neurological Disorders and Stroke, Bethesda, MD
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor A. Del Brutto
aDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitchell SV Elkind
eDepartment of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph L. Sacco
aDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Gut microbiota may impact cognitive function and decline, though data is limited. This pilot study examines the associations between gut dysbiosis products, plasma lipopolysaccharide (LPS) and soluble CD14 (sCD14), with cognitive decline and immune molecule activation among 40 participants in the longitudinal population-based Northern Manhattan Study.

Methods We selected stroke- and dementia-free participants at baseline with high activation levels of core components of the immune signaling pathways underlying microbiota metabolite-cognitive associations (IL-1, IL-17, TNF). Participants were followed with up to three complete neuropsychological assessments.

Results Elevated sCD14 was associated with high levels of IL-1 (p<0.05), whereas in samples where only IL-17 and TNF were increased, LPS and sCD14 levels were not elevated. LPS was associated with decline in global cognitive performance over 2-3 assessments (adjusted β=-0.023 per SD per year, 95%CI:-0.036, −0.010). The association between sCD14 and cognitive decline was marginal (adjusted β=-0.018 per SD per year, 95%CI:-0.040, 0.004).

Conclusions These preliminary data support the hypothesis that gut dysbiosis leads to systemic and neuro-inflammation, and subsequently cognitive decline. Further large targeted and untargeted gut microbiota-derived metabolomic studies are needed.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Not a clinical trial

Funding Statement

National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01 NS 29993)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the IRBs of Columbia University and the University of Miami, and all subjects provided written informed consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Anonymized data will be shared by request from any qualified investigator.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 18, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study
Tatjana Rundek, Sabita Roy, Mady Hornig, Ying Kuen Cheung, Hannah Gardener, Janet DeRosa, Bonnie Levin, Clinton B. Wright, Victor A. Del Brutto, Mitchell SV Elkind, Ralph L. Sacco
medRxiv 2020.09.15.20195362; doi: https://doi.org/10.1101/2020.09.15.20195362
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study
Tatjana Rundek, Sabita Roy, Mady Hornig, Ying Kuen Cheung, Hannah Gardener, Janet DeRosa, Bonnie Levin, Clinton B. Wright, Victor A. Del Brutto, Mitchell SV Elkind, Ralph L. Sacco
medRxiv 2020.09.15.20195362; doi: https://doi.org/10.1101/2020.09.15.20195362

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (557)
  • Anesthesia (135)
  • Cardiovascular Medicine (1769)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10812)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2960)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1933)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12525)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2808)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5383)
  • Radiology and Imaging (1016)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)